Reza Kiarash

1.8k total citations
11 papers, 521 citations indexed

About

Reza Kiarash is a scholar working on Oncology, Molecular Biology and Cell Biology. According to data from OpenAlex, Reza Kiarash has authored 11 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Cell Biology. Recurrent topics in Reza Kiarash's work include Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Reza Kiarash is often cited by papers focused on Microtubule and mitosis dynamics (5 papers), Cancer-related Molecular Pathways (4 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Reza Kiarash collaborates with scholars based in Canada, New Zealand and United States. Reza Kiarash's co-authors include Jean Gariépy, Tak W. Mak, Jasbir Sandhu, Aaron Hendler, Mark R. Bray, Graham C. Fletcher, Ross Cameron, Katherine A. Vallis, Jacqueline M. Mason and Wei Xin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Cancer Cell.

In The Last Decade

Reza Kiarash

10 papers receiving 514 citations

Peers

Countries citing papers authored by Reza Kiarash

Since Specialization

Citations

This map shows the geographic impact of Reza Kiarash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reza Kiarash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reza Kiarash more than expected).

Fields of papers citing papers by Reza Kiarash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reza Kiarash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reza Kiarash. The network helps show where Reza Kiarash may publish in the future.

Co-authorship network of co-authors of Reza Kiarash

This figure shows the co-authorship network connecting the top 25 collaborators of Reza Kiarash. A scholar is included among the top collaborators of Reza Kiarash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reza Kiarash. Reza Kiarash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	The spindle assembly checkpoint is a therapeutic vulnerability of CDK4/6 inhibitor–resistant ER ⁺ breast cancer with mitotic aberrations 2022 ·Science Advances ·Isabel Soria‐Bretones, Kelsie L. Thu, Jennifer Silvester, Jennifer Cruickshank, Samah El Ghamrasni, Wail Ba-Alawi, Graham C. Fletcher, Reza Kiarash, Mitchell J. Elliott, (unknown), (unknown), (unknown), April A. N. Rose, Mark R. Bray, Benjamin Haibe‐Kains, Tak W. Mak, David W. Cescon	26
2	Abstract 1642: Evaluation of ENMD-2076 in combination with anti-PD1 in syngeneic cancer models 2017 ·Cancer Research ·Graham C. Fletcher, Reza Kiarash, Mark R. Bray, (unknown), (unknown)	1
3	Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer 2017 ·Proceedings of the National Academy of Sciences ·Jacqueline M. Mason, Wei Xin, Graham C. Fletcher, Reza Kiarash, Richard D. Brokx, Richard Hodgson, I. P. Beletskaya, Mark R. Bray, Tak W. Mak	92
4	Functional Characterization of CFI-400945, a Polo-like Kinase 4 Inhibitor, as a Potential Anticancer Agent 2014 ·Cancer Cell ·Jacqueline M. Mason, Dan Lin, Wei Xin, Yi Che, Yi Yao, Reza Kiarash, David W. Cescon, Graham C. Fletcher, Donald E. Awrey, Mark R. Bray, Guohua Pan, Tak W. Mak	142
5	Abstract B267: Inhibition of PLK4 as a therapeutic strategy for genomically unstable cancers deficient for PTEN. 2013 ·Molecular Cancer Therapeutics ·Jacqueline M. Mason, Dan Lin, Xin Wei, (unknown), Yi Yao, Reza Kiarash, Graham C. Fletcher, Mark R. Bray, Guohua Pan, Tak W. Mak	0
6	Abstract LB-215: Inhibition of Polo-like kinase 4 as an anti-cancer strategy 2011 ·Cancer Research ·Jacqueline M. Mason, (unknown), Xunyi Luo, Vincent Nadeem, Reza Kiarash, Ping Huang, (unknown), Genie Leung, I. P. Beletskaya, Miklós Fehér, (unknown), (unknown), Peter B. Sampson, Sze-Wan Li, Yong Liu, Yunhui Lang, Henry W. Pauls, Tak W. Mak, James Pan	4
7	An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo 2010 ·Molecular Cancer ·Melissa Cheung, (unknown), (unknown), Xin Wei, Reza Kiarash, David E. Green, Aws Abdul‐Wahid, Jean Gariépy	12
8	Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with 111In 2001 ·Nuclear Medicine Communications ·Raymond M. Reilly, Paramita Maiti, Reza Kiarash, (unknown), (unknown), (unknown), (unknown), Saran A. Narang, Simon J. Foote, Howard A. Kaplan	7
9	111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR. 2000 ·PubMed ·Raymond M. Reilly, Reza Kiarash, Ross Cameron, (unknown), Jasbir Sandhu, Rićhard P. Hill, Katherine A. Vallis, Aaron Hendler, Jean Gariépy	113
10	A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer. 2000 ·PubMed ·(unknown), Reza Kiarash, Jasbir Sandhu, (unknown), Ross Cameron, Aaron Hendler, Katherine A. Vallis, Jean Gariépy	94
11	Penetration and Intracellular Routing of Nucleus-Directed Peptide-Based Shuttles (Loligomers) in Eukaryotic Cells 1998 ·Biochemistry ·(unknown), Reza Kiarash, Kim S. Kawamura, Eric C. LaCasse, Jean Gariépy	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact